全文获取类型
收费全文 | 9145篇 |
免费 | 1053篇 |
国内免费 | 3篇 |
出版年
2023年 | 49篇 |
2022年 | 60篇 |
2021年 | 282篇 |
2020年 | 146篇 |
2019年 | 193篇 |
2018年 | 211篇 |
2017年 | 199篇 |
2016年 | 364篇 |
2015年 | 569篇 |
2014年 | 571篇 |
2013年 | 587篇 |
2012年 | 756篇 |
2011年 | 784篇 |
2010年 | 501篇 |
2009年 | 394篇 |
2008年 | 555篇 |
2007年 | 549篇 |
2006年 | 428篇 |
2005年 | 431篇 |
2004年 | 433篇 |
2003年 | 380篇 |
2002年 | 347篇 |
2001年 | 95篇 |
2000年 | 72篇 |
1999年 | 83篇 |
1998年 | 93篇 |
1997年 | 56篇 |
1996年 | 75篇 |
1995年 | 41篇 |
1994年 | 55篇 |
1993年 | 35篇 |
1992年 | 48篇 |
1991年 | 51篇 |
1990年 | 40篇 |
1989年 | 37篇 |
1988年 | 20篇 |
1987年 | 29篇 |
1986年 | 23篇 |
1985年 | 38篇 |
1984年 | 38篇 |
1983年 | 36篇 |
1982年 | 28篇 |
1981年 | 35篇 |
1980年 | 32篇 |
1979年 | 31篇 |
1978年 | 36篇 |
1977年 | 27篇 |
1976年 | 21篇 |
1971年 | 20篇 |
1970年 | 23篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
121.
Claramma M. Chacko Rebecca S. Wappner Ira K. Brandt Henry L. Nadler 《Human genetics》1977,37(3):261-270
Summary A new variant of clinical galactosemia with two hitherto unidentified alleles on the transferase locus in one family is described. This new clinical variant of transferase has 25% of normal control activity in blood and in skin fibroblasts, and the patient accumulates galactose-1-phosphate in blood on an unrestricted galactose diet. Using starch gel electrophoresis on the hemolysate of the family members, a fast-moving transferase with mobility in between those of the normal control and of the Duarte variant is identified. This new allele is designated as
(fast-moving Chicago variant). In addition, a second new allele was documented in this family by studying the instability of the transferase enzyme in hemolysates of family members at 50°C for various time intervals. This new allele is designated as
(heat-labile Chicago variant). On the basis of the studies, the transferase genotype of this patients is thought to be a double heterozygote compound,
/GALTG. 相似文献
122.
123.
D J Back A M Breckenridge F E Crawford K J Cross M L Orme P H Rowe E Smith K Todd 《Life sciences》1978,23(10):1053-1056
87.9% of a given dose of [3H]Norethisterone ([3H]N) and 76.7% of [3H]Ethinyloestradiol ([3H]EE2) were excreted in the bile of male heterozygous Gunn rats in 2 hours Similarly, 86.9% of a given dose [3H]N and 84.0% of [3H]EE2 were excreted in the bile of male homozygous Gunn rats in 2 hours. In both heterozygous and homozygous rats glucuronide conjugates were present. Despite the lesion in UDP-glucuronyltransferase, the homozygous rats is able to conjugate the synthetic steroids apparently normally. 相似文献
124.
D.J. Back A.M. Breckenridge Francesca E. Crawford M.LE. Orme P.H. Rowe T.P. Sloan Eileen Smith 《Steroids》1978,32(4):423-433
The disappearance of ethinylestradiol from the blood of rabbits has been studied, following the intravenous administration of this steroid. The disappearance followed two exponentials, the first having a half life () of 5.5 min and the second, apparently terminal exponential was also rapid (). The plasma clearance was 150 ml/min which suggests almost total clearance of this steroid during a single passage through the liver. Bile contained a significant concentration of EE conjugates and thus this steroid could undergo enterohepatic recirculations. A large oral dose of unlabelled EE, given prior to intravenous administra tion of tritiated EE, considerably altered the pharmacokinetics of the latter by saturating both phase one metabolism (changes of the steroid nucleus) and the secretion of conjugates into bile. It was not clear whether phase two metabolism (conjugation) was also saturated. 相似文献
125.
Harvey R. Herschman Dennis S. Passovoy Rebecca M. Pruss Aharon Aharonov 《Journal of cellular biochemistry》1978,8(3):263-268
The growth-promoting activities of fetal bovine serum, cortisol, phorbol myristate acetate, prostaglandin F2α, insulin, epidermal growth factor, and fibroblast growth factor were evaluated on four murine embryo cell lines (Swiss 3T3, Balb 3T3, M2, and C3H10T1/2). Each cell had an unique response spectrum to this collection of reported mitogens. Phorbol myristate acetate and prostaglandin F2α were active only on selected cell lines; cortisol was inactive on all four lines. Serum, epidermal growth factor, and fibroblast growth factor were able to stimulate cell division in all four lines, albeit to varying degrees for the different target cells. 相似文献
126.
Differences in growth response to hydrocortisone and ascorbic acid by human diploid fibroblasts 总被引:2,自引:0,他引:2
David W. Rowe Barbra J. Starman Wilfred Y. Fujimoto Robert H. Williams 《In vitro cellular & developmental biology. Plant》1977,13(12):824-830
Summary The effects of hydrocortisone and ascorbic acid on growth parameters were measured in human diploid skin fibroblasts from
fetal and adult donors. In the presence of culture medium containing 10% fetal bovine serum, 0.3 μM hydrocortisone produced
a 20% increase in the population growth rate and a 50 to 70% increase in the confluent density of fibroblasts from adult donors.
Daily addition of 28 μM ascorbic acid also stimulated the population growth rate and cell density at confluency. The effects
of hydrocortisone and ascorbic acid on the final cell density were additive. The action of hydrocortisone was restricted to
cells in log-phase growth, whereas ascorbic acid affected cells in both the log and the postconfluent phases of the growth
cycle. In fibroblasts from fetal donors, ascorbic acid was stimulative but hydrocortisone was not. The data suggest that whereas
both compounds stimulate cell growth in an additive manner, they do so by different cellular mechanisms.
This investigation was supported in part by USPHS Grants AM 02456, AM 05020 and AM 15312, and by the Kroc Foundation, No.
UW 63-2986. Dr. Rowe is a fellow of the Helen Hay Whitney Foundation. Dr. Fujimoto is a recipient of a Research Career Development
Award, AM 47142, from NIAMDD. 相似文献
127.
B I Seneviratne I Linton R Wilkinson W Rowe M Spice 《BMJ (Clinical research ed.)》1983,286(6382):1924-1926
The cold pressor test was used to induce myocardial ischaemia in patients with coronary artery disease and the rise in left ventricular filling pressure used as the index of myocardial ischaemia. Left ventricular filling pressure was derived from a non-invasive echophonocardiographic method. A study group of 19 consecutive patients with chest pain underwent the cold pressor test before coronary angiography. Eighteen responded with a rise in filling pressure exceeding 30% and, of these, 17 had serious coronary artery disease (three single vessel, one two vessel, and 13 triple vessel disease; one had coronary artery spasm only). The remaining patient, who showed no rise in filling pressure, did not have coronary artery disease. None of 15 normal controls showed a rise greater than 5% (patients with coronary artery disease versus normal controls p less than 0.001). The cold pressor test would be suitable for patients who cannot or should not exercise and may be combined with exercise electrocardiograms to improve the information content, as it uses a different marker of myocardial ischaemia. 相似文献
128.
A steady-state kinetic analysis of the activation of bovine Factor X, by bovine Factor Xa, was undertaken. The activation was found to be dependent on the presence of divalent cations; Ca2+ showing the greatest stimulatory effect and Mn2+ exhibiting a lower degree of activity for this reaction. Although Sr2+ and Mg2+ were ineffective when present alone, each contributed synergistically to the activation rate at suboptimal levels of Ca2+. The effect of phospholipid (phosphatidylcholine:phosphatidylserine, 4:1, w:w) on the rate of activation and on the activation pathway was investigated. Phospholipid (PL) concentrations of up to 40 μm had no effect on the activation rate; whereas, concentrations of 40–180 μm were slightly inhibitory. In the absence of PL, the major product of the activation was Factor α-Xa, while in the presence of PL, lower-molecular-weight forms of Factor X (Factor β-X) and Factor Xa (Factor β-Xa were produced. At saturating levels of Ca2+, the Km app for the activation, at pH 7.4 and 37 °C, in the absence of PL, was found to be 0.6 ± 0.1 μm and the V was 1.7 ± 0.3 mol Factor X cleaved min?1 mol?1 Factor Xa. The corresponding values, in the presence of 90 μm PL, were 1.4 ± 0.2 μm and 2.2 ± 0.2 mol Factor X cleaved min?1 mol?1 Factor Xa. 相似文献
129.
130.
Michael Solursh Karen L. Jensen Carl T. Singley Thomas F. Linsenmayer Rebecca S. Reiter 《Developmental biology》1982,94(2):311-325
The effect of developmental stage on chondrogenic capacity in high-density cell cultures of chick embryonic wing bud mesenchyme is examined. Mesenchyme from stage 19 embryos forms aggregates of closely associated cells which do not form cartilage matrix, nor contain significant levels of type II collagen that are detectable by immunofluorescence, unless they are treated with dibutyryl cyclic AMP. Mesenchyme from stage 24 embryonic wing buds in high-density cell cultures will spontaneously form cartilage, as defined by electron microscopy and immunofluorescence with antibody to type II collagen. Cultures prepared from stage 26 wings form numerous aggregates which fail to accumulate an Alcian blue-staining matrix and which resemble mesenchyme cells morphologically. However, because these cells show considerable intracellular immunofluorescence for type II collagen, they are actually unexpressed cartilage cells. Several treatments, including exposure to dibutyryl cyclic AMP, ascorbic acid and an atmosphere of 5% oxygen, or mixture with small numbers of stage 24 wing mesenchyme cells, stimulate expression, as determined by the accumulation of an Alcian blue-staining matrix and an ultrastructurally recognizable cartilage matrix. Since the addition of similar numbers of differentiated cartilage cells does not stimulate expression of stage 26 cells, it is proposed that initial cartilage expression is dependent on a mesenchyme-specific influence which might be removed by cell dissociation. These studies demonstrate that there are at least two distinct transitions in cartilage differentiation: one involves the conversion of mesenchyme to unexpressed chondrocytes and the second involves mesenchyme-dependent expression of chondrogenic differentiation. 相似文献